Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Teriflunomide products are in shortage in Canada (2 of 5 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 30, 2026.
A medicine used to treat relapsing forms of multiple sclerosis.
Products affected
2 / 5
In shortage since
Jun 28, 2024
Est. full return
Sep 30, 2026
Reports on file
7
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-TERIFLUNOMIDE
14MG · TABLET · TEVA CANADA LIMITED
DIN 02501090 · since Nov 19, 2025, est. end Sep 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-TERIFLUNOMIDE
14MG · TABLET · TEVA CANADA LIMITED
DIN 02501090 · since Oct 8, 2025, est. end Sep 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACH-TERIFLUNOMIDE
14MG · TABLET · ACCORD HEALTHCARE INC
DIN 02502933 · since Jun 28, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ TERIFLUNOMIDE
14MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02505843 · ended Jan 23, 2026 · Disruption of the manufacture of the drug.
Discontinued
AUBAGIO
14MG · TABLET · SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN 02416328
Resolved
APO-TERIFLUNOMIDE
14MG · TABLET · APOTEX INC
DIN 02500639 · ended Jan 11, 2024 · Disruption of the manufacture of the drug.
Resolved
AUBAGIO
14MG · TABLET · SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN 02416328 · ended May 3, 2022
What's happening
Teriflunomide is currently affected by 2 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, ACCORD HEALTHCARE INC.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Recent changes
No changes recorded yet.
Common questions
What is Teriflunomide used for?
A medicine used to treat relapsing forms of multiple sclerosis.
When will Teriflunomide be back in stock in Canada?
The latest manufacturer estimate is Sep 30, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Teriflunomide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.